Medicxi Ventures Management (Jersey) Ltd - 10%+ Owner at Phathom Pharmaceuticals, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Medicxi Ventures Management (Jersey) Ltd since 05 Sep 2025

Reported holdings for Medicxi Ventures Management (Jersey) Ltd in Phathom Pharmaceuticals, Inc.

Form 4 holding 10%+ Owner

Phathom Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
3,673,602
Estimated value
$29,756,176
Report date
24 Jan 2024
Price
$8.10
Ownership
By Medicxi Growth I LP
Form 4 holding 10%+ Owner

Phathom Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
3,641,728
Estimated value
$29,497,997
Report date
24 Jan 2024
Price
$8.10
Ownership
By Medicxi IV LP
Form 4 holding 10%+ Owner

Phathom Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
87,267
Estimated value
$706,863
Report date
24 Jan 2024
Price
$8.10
Ownership
By Medicxi Growth Co-Invest I LP
Form 4 holding 10%+ Owner

Phathom Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
61,975
Estimated value
$501,998
Report date
24 Jan 2024
Price
$8.10
Ownership
By Medicxi Co-Invest IV LP

Transaction history for Medicxi Ventures Management (Jersey) Ltd in Phathom Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .